Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An update from Vita Life Sciences Limited ( (AU:VLS) ) is now available.
Vita Life Sciences Limited has announced an update on its ongoing share buy-back program, with a total of 12,824 ordinary fully paid securities bought back on the previous day. This move is part of a strategic effort to consolidate its share capital, potentially enhancing shareholder value and signaling confidence in the company’s financial health.
The most recent analyst rating on (AU:VLS) stock is a Buy with a A$2.50 price target. To see the full list of analyst forecasts on Vita Life Sciences Limited stock, see the AU:VLS Stock Forecast page.
More about Vita Life Sciences Limited
Vita Life Sciences Limited operates in the health and wellness industry, focusing on the production and distribution of vitamins and supplements. The company targets a market that values health enhancement and preventive healthcare solutions.
Average Trading Volume: 10,266
Technical Sentiment Signal: Buy
Current Market Cap: A$134.7M
Find detailed analytics on VLS stock on TipRanks’ Stock Analysis page.

